The gut microbiota has been linked to metabolic diseases. However, information on the
microbiome of young adults at risk for type 2 diabetes (T2D) is lacking. The aim of this cross-…

Context: The pathogenesis of type 2 diabetes (T2D) is still incompletely understood. In-depth
phenotyping of young individuals at risk for T2D can contribute to the understanding of this …

Aims/hypothesis Many individuals who develop type 2 diabetes also display increased
glucagon levels (hyperglucagonaemia), which we have previously found to be associated with …

Metformin is the most important first-line treatment for type 2 diabetes mellitus (T2DM) but its
exact mode of action remains unknown. In this study, we used targeted metabolomics to …

Objective The occurrence of pneumonia separates severe cases of COVID-19 from the majority
of cases with mild disease. However, the factors determining whether or not pneumonia …

Context The role of hyperglucagonemia in type 2 diabetes is still debated. Objective We
analyzed glucagon dynamics during oral glucose tolerance tests (oGTTs) in young women with …

Objective Clinically, type 2 diabetes mellitus (T2DM) is heterogeneous, but the prevailing
pathophysiologic hypothesis nevertheless contends that components of metabolic syndrome …

Objective Many anecdotal reports indicate the presence of ‘long COVID’ – COVID-19-related
symptoms weeks to months after the acute illness. However, frequency and symptom-…

Introduction Ten years ago, Germany started offering screening for gestational diabetes
mellitus (GDM) to all pregnant women. This approach revealed more but also, on average, less …

Aims Women after gestational diabetes mellitus (GDM) are a risk group for cardiometabolic
diseases but are hard to reach by conventional lifestyle programs. Therefore, we tested …